Trade Mark Journal No.2026/030 24 July 2026
WO0000001911861 (1,5,40,42)
Office of origin: United States of America
Date of International Registration:12 February 2026
Date of designation in the UK:
12 February 2026
International priority date claimed: 5 September 2025
(United States of America)
(99376736)
- Class 1
- Enzymes for scientific and research purposes; enzyme substrates for scientific purposes; peptide substrates for scientific purposes.
- Class 5
- Enzyme preparations for medical purposes; enzymes for medical purposes; enzyme substrates for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes in the nature of peptide substrates.
- Class 40
- Conversion of targeted substrates into targeted chemical preparation by treatment with enzyme systems.
- Class 42
- Biotechnology research; research and development in the field of biotechnology; research and development of antibody-drug conjugates; research and development of conjugated antibodies; research and development of drug conjugates; laboratory services for biomanufacturing; laboratory services for biomanufacturing peptides; laboratory services for biomanufacturing enzymes; laboratory services for biomanufacturing peptide substrates; laboratory services for biomanufacturing enzyme substrates.
Ridge Biotechnologies, Inc.
Representative: Scott A. Lund Dicke, Billig & Czaja, PLLC, 100 South Fifth Street, Suite 2250, Minneapolis MN 55402, UNITED STATES OF AMERICA